当前位置：药药网 / 数据中心 /靶点针对疾病信息(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息13(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
INDICATI
Approved Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Approved Gout [ICD-11: FA25]
INDICATI
Phase 2 Sarcoma [ICD-11: 2A60-2C35]
INDICATI
Phase 1/2 Brain cancer [ICD-11: 2A00]
INDICATI
Phase 1 Epidermal dysplasias [ICD-11: EK90]
INDICATI
Discontinued in Phase 3 Bladder cancer [ICD-11: 2C94]
INDICATI
Discontinued in Phase 1 Immune system disease [ICD-11: 4A01-4B41]
INDICATI
Investigative Central nervous system disease [ICD-11: 8A04-8D87]